160 related articles for article (PubMed ID: 31908396)
1. Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms.
Nardelli S; Riggio O; Rosati D; Gioia S; Farcomeni A; Ridola L
World J Gastroenterol; 2019 Dec; 25(48):6928-6938. PubMed ID: 31908396
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt.
Youssef NF; El Kassas M; Farag A; Shepherd A
BMC Gastroenterol; 2017 Jan; 17(1):18. PubMed ID: 28109264
[TBL] [Abstract][Full Text] [Related]
3. Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients.
Nardelli S; Pentassuglio I; Pasquale C; Ridola L; Moscucci F; Merli M; Mina C; Marianetti M; Fratino M; Izzo C; Merkel C; Riggio O
Metab Brain Dis; 2013 Jun; 28(2):239-43. PubMed ID: 23296469
[TBL] [Abstract][Full Text] [Related]
4. Role of Direct-Acting Antivirals in Hepatitis C Virus-Positive Castleman Disease.
Tahir M; Charles L
Am J Ther; 2018; 25(6):e733-e734. PubMed ID: 29557805
[No Abstract] [Full Text] [Related]
5. Evidence of HCV recovery after therapy of hepatitis C virus infection by direct acting antivirals.
Parlati L; Sirmai L; Dupuy CA; Glotz D; Pol S
Clin Res Hepatol Gastroenterol; 2019 Apr; 43(2):e18-e19. PubMed ID: 30293896
[No Abstract] [Full Text] [Related]
6. Hepatitis C virus treatment response to ledipasvir/sofosbuvir among patients coinfected with HIV and HCV: Real world data in a black population.
Banga J; Nizami S; Slim J; Nagarakanti S; Portilla M; Swaminathan S
Medicine (Baltimore); 2020 Mar; 99(11):e19140. PubMed ID: 32176039
[TBL] [Abstract][Full Text] [Related]
7. Trends in Renal Function Among Heart Transplant Recipients of Donor-Derived Hepatitis C Virus.
Zalawadiya SK; Lindenfeld J; Shah A; Wigger M; Danter M; Brinkley DM; Menachem J; Punnoose L; Balsara K; Brown Sacks S; Ooi H; Perri R; Awad J; Smith S; Fowler R; O'Dell H; Darragh C; Ruzevich-Scholl S; Schlendorf K
ASAIO J; 2020 May; 66(5):553-558. PubMed ID: 31425256
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.
Liu CJ; Chuang WL; Sheen IS; Wang HY; Chen CY; Tseng KC; Chang TT; Massetto B; Yang JC; Yun C; Knox SJ; Osinusi A; Camus G; Jiang D; Brainard DM; McHutchison JG; Hu TH; Hsu YC; Lo GH; Chu CJ; Chen JJ; Peng CY; Chien RN; Chen PJ
Gastroenterology; 2018 Mar; 154(4):989-997. PubMed ID: 29174546
[TBL] [Abstract][Full Text] [Related]
9. Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population.
Stewart RA; MacDonald BR; Chu TC; Moore JD; Fasanmi EO; Ojha RP
Dig Dis Sci; 2018 Dec; 63(12):3233-3240. PubMed ID: 30014226
[TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
[TBL] [Abstract][Full Text] [Related]
11. Multicenter Experience using Ledipasvir/Sofosbuvir ± RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment.
Aqel B; Leise M; Vargas HE; Watt KD; Keaveny AP; Zhang N; Zhang N; Pungpapong S
Ann Hepatol; 2018 Aug; 17(5):815-821. PubMed ID: 30145562
[TBL] [Abstract][Full Text] [Related]
12. Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).
Carrieri MP; Protopopescu C; Younossi Z; Vilotitch A; Fontaine H; Petrov-Sanchez V; Marcellin F; Carrat F; Hézode C; Bourlière M;
Patient; 2017 Oct; 10(5):605-614. PubMed ID: 28353221
[TBL] [Abstract][Full Text] [Related]
13. Two Antiviral Drugs Approved For Adolescents With HCV.
Aschenbrenner DS
Am J Nurs; 2017 Aug; 117(8):22. PubMed ID: 28749879
[No Abstract] [Full Text] [Related]
14. Hepatitis C virus serologic relapse after treatment with direct-acting antivirals is dependent on viral RNA levels in peripheral blood mononuclear cells and the grade of liver cirrhosis.
Abd Alla MDA; El Awady MK; Dawood RM; Elhawary MA; Al-Azhari SS; Galal AGM
Arch Virol; 2018 Oct; 163(10):2765-2774. PubMed ID: 29971486
[TBL] [Abstract][Full Text] [Related]
15. Successful evolution of morphea after hepatitis C virus eradication with direct-acting antiviral agent treatment.
Guerra Romero AR; Pérez Figueras M; Alonso López S
Rev Esp Enferm Dig; 2019 Dec; 111(12):973. PubMed ID: 31696725
[TBL] [Abstract][Full Text] [Related]
16. Drug-Drug Interactions in Children and Adolescents Receiving Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C Virus Infection.
Abdullatif HM; Ramzi R; Mogahed EA; Ghobrial CM; El Rasheed Abd El Zaher BA; El Raziky MS; El-Karaksy HM
Clin Drug Investig; 2019 Sep; 39(9):857-864. PubMed ID: 31240576
[TBL] [Abstract][Full Text] [Related]
17. A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan.
Kawaguchi I; Chayama K; Gonzalez YS; Virabhak S; Mitchell D; Yuen C; Kumada H
Adv Ther; 2020 Jan; 37(1):457-476. PubMed ID: 31808054
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients.
Maasoumy B; Buggisch P; Mauss S; Boeker KHW; Müller T; Günther R; Zimmermann T; Manns MP; Sarrazin C; Hüppe D; Wedemeyer H; Vermehren J
Liver Int; 2018 Nov; 38(11):1906-1910. PubMed ID: 30022590
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Ledipasvir/Sofosbuvir and Predictors of Treatment Failure in Members with Hepatitis C Genotype 1 Infection: A Retrospective Cohort Study in a Medicaid Population.
Kouris G; Hydery T; Greenwood BC; Lavitas P; Price M; Clements K; Alper CJ; Lenz K; Jeffrey PL
J Manag Care Spec Pharm; 2018 Jul; 24(7):591-597. PubMed ID: 29952708
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of sofosbuvir based direct-acting antiviral regimens for chronic hepatitis C virus genotype 6 patients: Real-world experience in Vietnam.
Nguyen DT; Tran TTT; Nghiem NM; Le PT; Vo QM; Day J; Rahman M; Le HM
PLoS One; 2020; 15(5):e0233446. PubMed ID: 32433676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
